| Dr Damon Ray Olson, MD | |
|
2525 Chicago Ave, Minneapolis, MN 55404-4518 | |
| (612) 813-6000 | |
| Not Available |
| Full Name | Dr Damon Ray Olson |
|---|---|
| Gender | Male |
| Speciality | Pathology - Pediatric Pathology |
| Location | 2525 Chicago Ave, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114283173 | NPI | - | NPPES |
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
According to the study published online in the Journal of Epidemiology & Community Health, regular and occasional use of cannabis as an adolescent is linked with a greater risk of other illicit drug consumption in early adulthood. The study by Bristol's Population Health Science Institute also found that cannabis use was connected with harmful drinking and smoking. One in five adolescents are at a risk of tobacco dependency, harmful alcohol consumption, and illicit drug use.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
Springer has signed a book partnership agreement with the American Physiological Society (APS) to publish titles in three APS book series as well as individual monographs and contributed volumes. The new publications are aimed primarily at researchers and will support Springer's growing physiology publishing program.
› Verified 6 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
According to the study published online in the Journal of Epidemiology & Community Health, regular and occasional use of cannabis as an adolescent is linked with a greater risk of other illicit drug consumption in early adulthood. The study by Bristol's Population Health Science Institute also found that cannabis use was connected with harmful drinking and smoking. One in five adolescents are at a risk of tobacco dependency, harmful alcohol consumption, and illicit drug use.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
Springer has signed a book partnership agreement with the American Physiological Society (APS) to publish titles in three APS book series as well as individual monographs and contributed volumes. The new publications are aimed primarily at researchers and will support Springer's growing physiology publishing program.
› Verified 6 days ago
| Entity Name | Children's Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932208808 PECOS PAC ID: 2668370966 Enrollment ID: O20040406000939 |
News Archive
According to the study published online in the Journal of Epidemiology & Community Health, regular and occasional use of cannabis as an adolescent is linked with a greater risk of other illicit drug consumption in early adulthood. The study by Bristol's Population Health Science Institute also found that cannabis use was connected with harmful drinking and smoking. One in five adolescents are at a risk of tobacco dependency, harmful alcohol consumption, and illicit drug use.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
Springer has signed a book partnership agreement with the American Physiological Society (APS) to publish titles in three APS book series as well as individual monographs and contributed volumes. The new publications are aimed primarily at researchers and will support Springer's growing physiology publishing program.
› Verified 6 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
According to the study published online in the Journal of Epidemiology & Community Health, regular and occasional use of cannabis as an adolescent is linked with a greater risk of other illicit drug consumption in early adulthood. The study by Bristol's Population Health Science Institute also found that cannabis use was connected with harmful drinking and smoking. One in five adolescents are at a risk of tobacco dependency, harmful alcohol consumption, and illicit drug use.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
Springer has signed a book partnership agreement with the American Physiological Society (APS) to publish titles in three APS book series as well as individual monographs and contributed volumes. The new publications are aimed primarily at researchers and will support Springer's growing physiology publishing program.
› Verified 6 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
According to the study published online in the Journal of Epidemiology & Community Health, regular and occasional use of cannabis as an adolescent is linked with a greater risk of other illicit drug consumption in early adulthood. The study by Bristol's Population Health Science Institute also found that cannabis use was connected with harmful drinking and smoking. One in five adolescents are at a risk of tobacco dependency, harmful alcohol consumption, and illicit drug use.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
Springer has signed a book partnership agreement with the American Physiological Society (APS) to publish titles in three APS book series as well as individual monographs and contributed volumes. The new publications are aimed primarily at researchers and will support Springer's growing physiology publishing program.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Damon Ray Olson, MD 5901 Lincoln Drive, Cbc-2-rev/pe, Edina, MN 55436-1611 Ph: () - | Dr Damon Ray Olson, MD 2525 Chicago Ave, Minneapolis, MN 55404-4518 Ph: (612) 813-6000 |
News Archive
According to the study published online in the Journal of Epidemiology & Community Health, regular and occasional use of cannabis as an adolescent is linked with a greater risk of other illicit drug consumption in early adulthood. The study by Bristol's Population Health Science Institute also found that cannabis use was connected with harmful drinking and smoking. One in five adolescents are at a risk of tobacco dependency, harmful alcohol consumption, and illicit drug use.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the areas of dermatology and ophthalmology, today announced that it received a Notice of Allowance from the United States Patent and Trademark Office on its novel, self-delivering RNAi platform (sd‑rxRNA).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
Springer has signed a book partnership agreement with the American Physiological Society (APS) to publish titles in three APS book series as well as individual monographs and contributed volumes. The new publications are aimed primarily at researchers and will support Springer's growing physiology publishing program.
› Verified 6 days ago
Khalid Amin, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St Se, C463 Mayo Memorial Bldg, Mayo Mail Code 76, Minneapolis, MN 55455 Phone: 913-827-3505 | |
Dr. Laura L Schmitz, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Minneapolis, MN 55422 Phone: 763-581-4150 Fax: 763-581-4151 | |
Dr. Michael Patrick Greenwood, MD Pathology Medicare: Medicare Enrolled Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Deborah Elizabeth Powell, MD Pathology Medicare: Medicare Enrolled Practice Location: 500 Harvard St Se, Lab Med & Pathology, Minneapolis, MN 55455 Phone: 612-273-1142 | |
Yiang Hui, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave S Ste 2200, Minneapolis, MN 55407 Phone: 612-767-8373 | |
Dr. Pamela Ann Sakkinen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave S Ste 2200, Hospital Pathology Assoc, Minneapolis, MN 55407 Phone: 612-767-8370 Fax: 612-767-8376 | |
Kevin Todd Stieglbauer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave S Ste 2200, Hospital Pathology Assoc, Minneapolis, MN 55407 Phone: 612-767-8370 Fax: 612-767-8376 |